Xylem Inc. filings document the regulatory disclosures of a public operating company focused on water solutions and resource management. Recent Form 8-K reports furnish quarterly and annual financial results, including press-release exhibits for orders, revenue, earnings measures and guidance-related disclosures.
Other Xylem filings record capital actions such as common-stock repurchase authorization, while definitive proxy materials cover governance, shareholder voting matters and executive compensation disclosures, including equity-award and pay-versus-performance information.
Xylem Inc. (XYL) director Victoria D. Harker reported an open‑market sale of 1,700 shares of common stock at a weighted average price of $148.14 on November 4, 2025. According to the Form 4, the shares were executed within a price range of $148.135 to $148.135.
Following the transaction, Harker beneficially owns 16,875 shares directly. The filing lists no derivative securities transactions.
Xylem (XYL) received a Form 144 notice indicating a planned sale of 1,700 common shares, with an aggregate market value of $251,829.50. The planned sale lists Morgan Stanley Smith Barney LLC as broker and targets the NYSE, with an approximate sale date of 11/04/2025.
The filing lists prior acquisitions via restricted stock vesting under a registered plan on 05/11/2015 (1,213 shares) and 05/10/2016 (487 shares). It also discloses a sale during the past three months: 1,800 shares for $258,541.74 on 08/04/2025 by Victoria Harker. Xylem had 243,469,063 shares outstanding as of the disclosure.
Xylem Inc. (XYL) reported an insider transaction by EVP, CPSO Claudia S. Toussaint. On 10/30/2025, a revocable trust for which she is trustee sold 10,421 shares of common stock at a weighted average price of $152.64, with executions ranging from $152.51 to $152.98. Following the sale, the filing shows 31,250 shares indirectly owned by the Claudia S. Toussaint Revocable Trust and 3,939 shares directly owned.
Form 144 filing: A stockholder filed notice to sell up to 10,421 shares of common stock, with an aggregate market value of $1,590,557.23. The planned sales may occur on the NYSE around 10/30/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services.
The shares were acquired via restricted stock vesting under a registered plan on 02/21/2019 (1,401 shares), 02/27/2023 (3,792), 03/01/2023 (1,185), and 03/01/2024 (4,043), totaling 10,421 shares. Shares outstanding were 243,469,063; this is a baseline figure, not the amount being offered.
Xylem Inc. reported Q3 results with revenue of $2,268 million, up from $2,104 million a year ago. Net income was $226 million and diluted EPS was $0.93, compared with $0.89 last year. Gross profit rose to $883 million and operating income increased to $334 million. Interest expense declined to $6 million. The quarter included a $37 million loss on sale of businesses.
For the first nine months, revenue reached $6,638 million and operating cash flow was $698 million. Cash and cash equivalents stood at $1,191 million, and total assets were $17,295 million. The company closed acquisitions of EnviroMix for $106 million and Simply Clean for $7 million, and completed the Vacom Systems asset acquisition with total consideration of $42 million. It divested the Evoqua Magneto business for $61 million and recorded a $39 million loss tied to classifying the international metering business as held for sale. Q3 restructuring charges were $23 million, with $70 million year-to-date.
Xylem Inc. (XYL) furnished a current report announcing it issued a press release with financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1.
The information is designated as “furnished,” not “filed,” under Section 18 of the Exchange Act and is incorporated by reference only if specifically noted in a future filing.
Xylem Inc. (XYL) insider filing: EVP & Pres, AW Meredith Emmerich reported a tax withholding transaction tied to RSU vesting. On 10/21/2025, 841 shares of common stock were withheld to cover taxes at a reported price of $147.19 (Transaction Code F).
Following this withholding, the reporting person directly beneficially owns 3,992 shares. The RSUs vested from an award granted on October 21, 2024 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
Xylem Inc. insider William K. Grogan had 4,254 shares of common stock withheld at a price of $142.18 on 09/18/2025 to cover taxes arising from the vesting of restricted stock units granted on 09/18/2023 under the Xylem 2011 Omnibus Incentive Plan. After the withholding, Grogan beneficially owns 28,199 shares, which figure also reflects additional shares from dividend reinvestment. The Form 4 was filed by one reporting person and executed by an attorney-in-fact on behalf of Mr. Grogan.
Geri-Michelle McShane, Vice President and Chief Accounting Officer of Xylem Inc. (XYL), reported a sale of 1,000 shares of Xylem common stock on 09/05/2025 at a weighted-average price of $139.962 per share (executed in a price range of $139.96–$139.98). After the transaction, the reporting person beneficially owned 2,957 shares of Xylem common stock. The Form 4 was signed by a power of attorney on behalf of the reporting person.
Xylem Inc. (XYL) Form 144 notifies a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $139,962. The filing lists the issuer's outstanding common shares as 243,409,688, and shows an approximate sale date of 09/05/2025. The shares reported were acquired primarily via the company's Employee Stock Purchase Plan in multiple small purchases between 03/23/2023 and 03/01/2024, with the largest single acquisition entries totaling 477, 322, and 136 shares.
The notice contains no reportable sales in the past three months and includes the standard representation that the seller is unaware of undisclosed material adverse information about the issuer.